YAP1 and cholangiocarcinoma: Given that Sox9 is a well-established direct target of NOTCH2 [16,17], we aimed to investigate the effects of cell-autonomous Sox9 deletion on lineage commitment in Akt-YAP1-driven cHCC-CCA tumorigenesis.